Barclays’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4K Sell
2,508
-37,363
-94% -$59.6K ﹤0.01% 4227
2025
Q1
$64K Sell
39,871
-9,989
-20% -$16K ﹤0.01% 3828
2024
Q4
$63K Buy
49,860
+6,925
+16% +$8.75K ﹤0.01% 3903
2024
Q3
$81K Buy
42,935
+32,784
+323% +$61.8K ﹤0.01% 3793
2024
Q2
$75K Sell
10,151
-9,218
-48% -$68.1K ﹤0.01% 3506
2024
Q1
$152K Sell
19,369
-18,347
-49% -$144K ﹤0.01% 3464
2023
Q4
$192K Buy
37,716
+33,064
+711% +$168K ﹤0.01% 3524
2023
Q3
$27K Sell
4,652
-533
-10% -$3.09K ﹤0.01% 3814
2023
Q2
$39K Sell
5,185
-50,477
-91% -$380K ﹤0.01% 3771
2023
Q1
$526K Buy
+55,662
New +$526K ﹤0.01% 2609
2020
Q3
Sell
-1,583
Closed -$18K 3725
2020
Q2
$18K Buy
1,583
+60
+4% +$682 ﹤0.01% 3577
2020
Q1
$9K Sell
1,523
-430
-22% -$2.54K ﹤0.01% 3491
2019
Q4
$13K Hold
1,953
﹤0.01% 3712
2019
Q3
$14K Hold
1,953
﹤0.01% 3875
2019
Q2
$14K Hold
1,953
﹤0.01% 3994
2019
Q1
$28K Hold
1,953
﹤0.01% 3837
2018
Q4
$23K Buy
1,953
+286
+17% +$3.37K ﹤0.01% 3348
2018
Q3
$37K Hold
1,667
﹤0.01% 3815
2018
Q2
$32K Buy
1,667
+667
+67% +$12.8K ﹤0.01% 3462
2018
Q1
$11K Buy
1,000
+500
+100% +$5.5K ﹤0.01% 3939
2017
Q4
$10K Hold
500
﹤0.01% 3821
2017
Q3
$9K Hold
500
﹤0.01% 3455
2017
Q2
$18K Hold
500
﹤0.01% 3291
2017
Q1
$23K Hold
500
﹤0.01% 3327
2016
Q4
$13K Buy
+500
New +$13K ﹤0.01% 3202
2015
Q3
Sell
-14
Closed -$1K 3951
2015
Q2
$1K Sell
14
-9
-39% -$643 ﹤0.01% 3994
2015
Q1
$2K Sell
23
-17
-43% -$1.48K ﹤0.01% 3892
2014
Q4
$6K Buy
40
+33
+471% +$4.95K ﹤0.01% 3897
2014
Q3
$1K Sell
7
-8
-53% -$1.14K ﹤0.01% 4199
2014
Q2
$3K Buy
+15
New +$3K ﹤0.01% 4009